美國的醫療市場預測:∼2013年 是由出版商RNCOS E-Services Pvt. Ltd.在2011年12月所出版的。
這份英文市場調查報告書包含80 Pages 價格從美金1000起跳。
美國的醫療市場由於高醫療費用而成為全球最大的市場。美國的醫療費用從2010年開始到2013年之間，年複利成長率(年複合成長率)約成長5％。
本報告提供美國的醫療市場相關調查，醫療服務及法規環境的不同市場區隔分析，市場課題分析，不同市場區隔的主要打入市場企業簡介，統計，疾病簡介等，為您概述為以下內容。
第1章 分析師的見解
第2章 調查手法
第3章 醫療市場概要
第4章 市場魅力
- 人口的高齡化與健康意識的高漲
- 文明病及慢性疾病的得病率的增加
- 政府的強力支援
- 緊接而來的行動醫療領域
第5章 醫療服務市場
- 醫院服務市場
- 醫藥品市場
- 醫療設備市場
- 醫療ＩＴ市場
- 醫療保險市場
第6章 法規環境
- 醫療改革:2010年
- 醫藥品市場
- 醫療設備市場
- 醫療ＩＴ市場
第7章 市場課題
- 醫療系統的效率性的缺乏
- 藥物敲詐
- 醫療的地區的差異
- 醫療廢棄物
第8章 市場參與企業:不同市場區隔
圖表
Abstract
The US represents the world's largest healthcare market, with a high annual
healthcare spending. The growth in healthcare spending is mainly driven by
high administrative costs, and expensive hospital care. We believe that the
market holds a great potential with several segments under healthcare spending
still remaining untapped, indicating immense opportunities for the industry
players for expanding operations. According to our report " US Healthcare
Market Outlook 2013" , the US healthcare spending is expected to grow at a
CAGR of around 5% during 2010-2013.
Our report covers the Hospital care, Pharmaceutical, Medical device,
Healthcare IT and Healthcare Insurance segments of the industry. Among several
market attractions in the US healthcare sector, M-health has been gaining
increasing market penetration, and is poised for a high future growth. Due to
increasing prevalence of chronic diseases and rising aging population, the
healthcare facilities are in great demand leading to growth in the sector.
The pharmaceutical market is a growing segment, with several global players
playing a major role. Our report gives a brief profile of these players, and
emphasizes the future growth of the pharma market. It also elaborates how the
latest technological advancements, which will make treatment and diagnosis
simpler and effective, would impact the medical device market.
However, the country faces some severe setbacks in the industry. The research
highlights the shortage of healthcare professionals which can impact the US
healthcare industry in the future. It also covers how the government is
striving to combat these issues.
The healthcare sector is regulated by the government, and the report covers
several legislations prevailing in the industry. How the government has been
trying to improve the healthcare sector performance by introducing several
reforms, including The Affordable Care Act of 2010, has also been discussed
along with its impact on the performance of each segment.
The report provides detailed statistical and analytical review of
demographics, disease profiles, and key drivers affecting the US healthcare
sector. It contains exhaustive information that will facilitate clients to
draw up market strategies and assess opportunities in the US healthcare market.
Table of Contents
1. Analyst View
2. Research Methodology
3. Healthcare Market Overview
4. Market Attractions
- 4.1 Rising Health Concerns with Ageing Population
- 4.2 Increasing Prevalence of Lifestyle and Chronic Diseases
- 4.3 Strong Government Support
- 4.4 Upcoming Field of Mobile Health
5. Healthcare Service Market
- 5.1 Hospital Service Market
- 5.1.1 Hospitals and Beds
- 5.1.2 Inpatients and Outpatients
- 5.1.3 Manpower Availability
- 5.2 Pharmaceutical Market
- 5.2.1 Market Overview
- 5.2.2 Generics and Branded Drugs
- 5.2.3 OTC and Prescription Drugs
- 5.2.4 Distribution Channel
- 5.3 Medical Device Market
- 5.3.1 Market Overview
- 5.3.2 Export and Import Analysis
- 5.4 Healthcare IT Market
- 5.5 Healthcare Insurance Market
6. Regulatory Environment
- 6.1 Healthcare Reform 2010
- 6.1.1 Impact of the Reform
- 6.2 Pharmaceutical Market
- 6.3 Medical Device Market
- 6.4 Healthcare IT Market
7. Industry Challenges
- 7.1 Lack of Efficiency in Healthcare System
- 7.2 Pill Pushing
- 7.3 Geographic Variation in Healthcare
- 7.4 Medical Wastage
8. Industry Players by Segment
- 8.1 Hospitals Market
- 8.2 Pharmaceutical Market
- 8.3 Medical Devices Market
- 8.4 Healthcare IT Market
List of Figures:
- Figure 3-1: National Healthcare Expenditure (Trillion US$), 2007-2010 &
2013
- Figure 3-2: National Health Expenditure by Source of Payment (%), 2009
- Figure 4-1: mHealth Market (Billion US$), 2009-2013
- Figure 5-1: Hospital Care Expenditure (Billion US$), 2004, 2009 & 2014
- Figure 5-2: Number of Hospitals (2006-2009)
- Figure 5-3: Number of Hospital Beds ('000), 2006-2009
- Figure 5-4: Share of Hospitals in Rural Areas based on Bed Size (2009)
- Figure 5-5: Share of Hospitals in Urban Areas based on Bed Size (2009)
- Figure 5-6: Outpatients Visit in Hospitals (Million), 2005-2008
- Figure 5-7: Pharmaceutical Market (Billion US$), 2008-2013
- Figure 5-8: Prescriptions Dispensed (Billion), 2006-2010
- Figure 5-9: Share of Generics and Branded Drugs in Pharmaceutical Market
(2010)
- Figure 5-10: Share of Generic Prescriptions in Total Prescriptions
(2006-2010)
- Figure 5-11: Prescription Drug Sales by Distribution Channel (%), 2010
- Figure 5-12: Medical Device Market (Billion US$), 2010-2013
- Figure 5-13: Medical Device Export by Region (%), 2007
- Figure 5-14: Medical Device Export by Product (%), 2008
- Figure 5-15: Medical Device Import by Product (%), 2008
- Figure 5-16: Healthcare IT Market (Billion US$), 2010-2013
- Figure 5-17: Percentage of Office-based Physicians Using EMRs/EHRs
(2006-2009)
- Figure 5-18: Healthcare Payment under Medicare and Medicaid Programs
(Billion US$), 2008-2013
- Figure 5-19: Healthcare Payment through Private Insurance (Billion US$),
2009-2013
List of Tables:
- Table 4-1: Demographic Characteristics (2008-2010)
- Table 4-2: Number of Deaths due to Leading Causes (2009)
- Table 5-1: Number of M&A Activity in US Healthcare Services Industry
(2006-2009 & H1 2010)
- Table 5-2: Inpatients Statistics in Hospitals (2005-2008)
- Table 5-3: Sales of Top Ten Therapies by Spending in Pharmaceutical Market
(Billion US$), 2010
- Table 5-4: Sales of Top Ten Products in Pharmaceutical Market (Billion
US$), 2010
- Table 5-5: Medical Equipment Technologies Subsectors
- Table 5-6: Top Medical Device Companies by Revenue (Billion US$), 2010
- Table 5-7: Potential Savings from Healthcare IT-enabled Efficiencies
- Table 5-8: E-prescription Statistics (2007-2009)
- Table 6-1: Affordable Care Act Timeline: Proposed Actions
- Table 8-1: Sales of Top Ten Companies in Pharmaceutical Market (Billion
US$), 2010
